CJC-1295 research guide for Maqueda. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
Most researchers seeking out CJC-1295 in Maqueda quickly find that local retail options are all but absent from local stores. What this means for Maqueda researchers is that your location matters far less than your ability to verify analytical documentation — and those quality checks are available to every researcher. What genuinely separates top CJC-1295 vendors is full COA coverage: HPLC for purity, mass spec for peptide identity confirmation, and endotoxin testing for safety documentation. This guide walks Maqueda researchers through that evaluation process and explains the signals that distinguish quality CJC-1295 suppliers.
How CJC-1295 Works — Mechanisms & Research
CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: CJC-1295 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Maqueda comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.
CJC-1295 Purchasing Guide
Before assessing any particular supplier, establish a quality benchmark — so you can tell whether a COA is complete and credible. Endotoxin testing in the COA is essential for any injectable research use — endotoxins from bacterial cell wall components can trigger severe inflammatory responses even at very low concentrations. For Maqueda researchers evaluating unfamiliar vendors: a small initial order to verify quality before placing larger orders is standard practice in the community. Price is an unreliable primary filter for CJC-1295 quality — research-grade synthesis and testing has unavoidable expenses that low-priced vendors are not absorbing, so significantly below-market pricing signals compromises.
Order CJC-1295 — ships to Maqueda
COA-verified · International tracking · Research grade
All use of CJC-1295 in Maqueda or anywhere must be research use only — this compound is not approved for therapeutic human application, and all handling should comply with standard research safety practices. Storage requirements for CJC-1295: lyophilised powder at −20°C, reconstituted solution refrigerated at 2-8°C and finished within 30 days of reconstitution; reconstitute only with bacteriostatic water. Verify the endotoxin level in your CJC-1295 batch COA before use in any in-vivo protocol — look for results expressed as EU/mg or EU/mL and compare against acceptable research limits for your application. PubMed and related preprint servers represent the most comprehensive research databases for CJC-1295 research; favour indexed journal publications over preprints over conference abstracts or single case observations.
Frequently Asked Questions
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
